OpenWorks @ MD Anderson
Not a member yet
4211 research outputs found
Sort by
A Comparative Study of Legacy and Modern Proton Therapy Pencil Beam Gantries in Prostate Cancer Treatment: Advancements in Efficiency and Performance
No full texthttps://openworks.mdanderson.org/rmps25/1007/thumbnail.jp
Evaluating The Impact Of Education And Assessment In Reducing Avoidable Revisits to the ACCC
No full textThe aim of this project is to reduce OP-35 revisit ratio in the Thoracic Service Line data by 5% by April 2025 from the baseline FY24 Q2 data.https://openworks.mdanderson.org/acif26/1004/thumbnail.jp
Corinne Linardic
No full textDr. Linardic is a physician-scientist in the Division of Pediatric Hematology-Oncology at Duke University School of Medicine in Durham, NC. Her clinical and research interest is pediatric sarcomas, with focus on the skeletal muscle cancer rhabdomyosarcoma. Dr. Linardic received her M.D., Ph.D., from Duke University School of Medicine, then completed pediatric residency training at the Children’s Hospital of Philadelphia (CHOP). After pediatric hematology-oncology fellowship training spanning CHOP and Duke, she joined the faculty at Duke. In addition to caring for pediatric hematology-oncology patients, she leads a basic science-translational lab and teaches and mentors trainees ranging from undergraduates to post-doctoral scientists affiliated with the Pharmacology & Cancer Biology Department and graduate training umbrella programs. She especially enjoys her work with the Children’s Oncology Group, the trans-Atlantic INSTRuCT Soft Tissue Sarcoma Consortium, NCI-supported inter-institutional efforts to target fusion oncoproteins in childhood cancers (FusOnC2 and TFCC) including the PAX3::FOXO1 fusion protein, and her collaborations with other rhabdomyosarcoma experts around the world. Her partnerships with patient advocacy groups are especially meaningful to her. Dr. Linardic is married to Dr. Edward Patz Jr., a thoracic radiologist with expertise in lung cancer and immuno-oncology, and they have two children, Chloe and Oliver. When she has a spare moment, Dr. Linardic’s other interests include travel, the Silk Road, and ancient DNA.https://openworks.mdanderson.org/kleinermanbios/1008/thumbnail.jp
Brock Lindsey
No full textDr. Lindsey is an orthopaedic surgeon specializing in orthopaedic oncology. He treats children and adults with all types of bone and soft tissue sarcomas. Dr. Lindsey has expertise in nanoparticle delivery of immunotherapy, immunodiagnostics as a novel treatment for osteosarcoma, as well as complex reconstruction after amputation, including osseointegration.
Dr. Lindsey earned his medical degree from the University of Cincinnati. He then completed an orthopaedic surgery residency at West Virginia University’s (WVU) J.W. Ruby Memorial Hospital, becoming the department’s first to complete a research fellowship during residency. Dr. Lindsey also pursued a fellowship in musculoskeletal oncology at the University of Pittsburgh Medical Center (UPMC) and UPMC Children’s Hospital before returning to WVU Medicine as an attending physician.
During his 12 years at WVU Medicine, Dr. Lindsey created programs in musculoskeletal oncology and adult reconstruction as well as a multidisciplinary amputation clinic. He also led a musculoskeletal research laboratory into the national rankings for federal funding for orthopaedic surgery departments. His research focuses on improving treatment strategies for metastatic osteosarcoma and exploring human/machine interfaces for amputees. His work has been published in local, national and international basic science and clinical research journals.
Dr. Lindsey has experience mentoring and training students at all levels from undergraduate and graduate students to postdoctoral positions. He won Press Ganey’s “Top Provider” award every year between 2013 and 2018. He also founded ICaPath, a biotech startup derived from his laboratory research that is currently working toward a first in-human clinical trial.https://openworks.mdanderson.org/kleinermanbios/1009/thumbnail.jp
C1D1: Ready Mind, One Call at a Time
No full textThis study explores how a standardized nurse-led phone call, conducted 24–48 hours before Cycle 1, Day 1 of chemotherapy, improved patient preparedness, reduced anxiety, and enhanced comprehension of treatment expectations and procedures.https://openworks.mdanderson.org/acif26/1008/thumbnail.jp
Library News December 2025
No full textReducing Barriers to Learning: MD Anderson\u27s OER Initiative How to Navigate Author Instructions (part 1) Best and Worst Books of 2025 A Noteworthy Article about Notable, Noteworthy, and Noticeablehttps://openworks.mdanderson.org/rmlnews25/1011/thumbnail.jp
Quantifying Interobserver Variability in Head and Neck Lymphedema Structure Segmentation
Get PDFhttps://openworks.mdanderson.org/catalyst24/1011/thumbnail.jp